Capgemini Shares Fall 4.24% at Close Following Morgan Stanley Downgrade

Market Reaction and Analyst Insights

Capgemini ended the day down 4.24% at 144.45 euros this Monday, following a decline from 150.85 euros the previous day. The significant drop is attributed to Morgan Stanley's downgrade, which lowered its recommendation from 'market-weight' to 'underweight' and its price target from 145 to 142 euros. The traded volume, representing 0.32% of the capital, indicates a cautious market sentiment towards the stock. The bank believes that the stock has rebounded from its lows near 120 euros, driven by a return to organic growth in the third quarter and a revaluation of the sector, but does not see a path to further expansion of valuation multiples. Morgan Stanley anticipates an organic growth of only 0.6% for 2025 and 2.5% for 2026, significantly lower than market expectations from a year earlier. The RSI at 57 reflects a neutral momentum, neither in overbought nor oversold territory, consistent with this anticipated slowdown.

Challenges in Market Perception and Sector Pressures

Morgan Stanley highlights that Capgemini's decision to eliminate direct communication of organic growth makes it more difficult for investors to assess trends, which could weigh on sentiment. The bank also points to price pressure in the IT services sector, linked to shifts in client spending priorities towards artificial intelligence and increased investment needs, factors that limit growth and margins. Technically, the stock is now slightly above its 50-day moving average at 138.18 euros, but remains under pressure with resistance at 151.85 euros. Morgan Stanley's price target of 142 euros implies a potential downside of 1.7% from the close, while J.P. Morgan offers a more favorable outlook with a target of 155 euros, suggesting an upside of 7.3%. This divergence of views reflects the uncertainty surrounding the company's growth trajectory in a competitive and inflationary environment.